<SEC-DOCUMENT>0000950170-25-108132.txt : 20250813
<SEC-HEADER>0000950170-25-108132.hdr.sgml : 20250813
<ACCEPTANCE-DATETIME>20250813165323
ACCESSION NUMBER:		0000950170-25-108132
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250813
DATE AS OF CHANGE:		20250813

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZIMMER BIOMET HOLDINGS, INC.
		CENTRAL INDEX KEY:			0001136869
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				134151777
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-61975
		FILM NUMBER:		251212520

	BUSINESS ADDRESS:	
		STREET 1:		345 EAST MAIN STREET
		CITY:			WARSAW
		STATE:			IN
		ZIP:			46580
		BUSINESS PHONE:		5742676131

	MAIL ADDRESS:	
		STREET 1:		345 EAST MAIN STREET
		CITY:			WARSAW
		STATE:			IN
		ZIP:			46580

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZIMMER HOLDINGS INC
		DATE OF NAME CHANGE:	20010315

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DODGE & COX
		CENTRAL INDEX KEY:			0000200217
		STANDARD INDUSTRIAL CLASSIFICATION:	UNKNOWN SIC - 0000 [0000]
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		555 CALIFORNIA STREET
		STREET 2:		40TH FLOOR
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		4159811710

	MAIL ADDRESS:	
		STREET 1:		555 CALIFORNIA STREET
		STREET 2:		40TH FLOOR
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0000950170-25-064570</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0000200217</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>4</amendmentNo>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>06/30/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001136869</issuerCik>
        <issuerName>ZIMMER BIOMET HOLDINGS, INC.</issuerName>
        <issuerCusip>98956P102</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">345 East Main Street</street1>
          <city xmlns="http://www.sec.gov/edgar/common">Warsaw</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">IN</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">46580</zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Dodge &amp; Cox</reportingPersonName>
      <citizenshipOrOrganization>CA</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>20878838</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>22097463</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>22097463</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>11.2</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>ZIMMER BIOMET HOLDINGS, INC.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>345 East Main Street, Warsaw, Indiana 46580</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Dodge &amp; Cox</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>555 California Street 40th Floor, San Francisco, CA 94104</principalBusinessOfficeOrResidenceAddress>
        <citizenship>California, USA</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>IA</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>22,097,463</amountBeneficiallyOwned>
        <classPercent>11.2</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>20,878,838</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>22,097,463</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>N</notApplicableFlag>
        <ownershipMoreThan5PercentOnBehalfOfAnotherPerson>The clients of Dodge &amp; Cox, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or power to direct the receipt of dividends from, and the proceeds from the sale of, ZIMMER BIOMET HOLDINGS, INC.

Dodge &amp; Cox Stock Fund, an investment company registered under the Investment Company Act of 1940, has an interest of 14,622,400 or 7.4%, of the class of securities reported herein.</ownershipMoreThan5PercentOnBehalfOfAnotherPerson>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Dodge &amp; Cox</reportingPersonName>
      <signatureDetails>
        <signature>/S/ Katherine M. Primas</signature>
        <title>Chief Compliance Officer</title>
        <date>08/13/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
